Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

December 12, 2024

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BURLINGTON, Mass. and JERUSALEM, Israel, December 12, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

November 19, 2024

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Reductions also seen in comorbid anxiety and depression symptoms BURLINGTON, Mass. and JERUSALEM, Israel,...

November 12, 2024

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41...

October 29, 2024

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

BURLINGTON, Mass. and JERUSALEM, Israel, October 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ...

October 9, 2024

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ...

September 30, 2024

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness,...

September 10, 2024

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ...

August 29, 2024

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer Dr. Bermudes Widely Considered...

August 6, 2024

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024 Recorded Positive Quarterly Net Income...

July 23, 2024

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

BURLINGTON, Mass. and JERUSALEM, Israel, July 23, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

June 17, 2024

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 10, 2024

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Shortened Acute Treatment Period Could Enhance Appeal and Market Opportunities of Deep TMS™ BURLINGTON,...

June 3, 2024

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between...

May 8, 2024

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income...

April 24, 2024

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

April 17, 2024

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates Company...

April 4, 2024

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson’s Disease

Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms JERUSALEM...

March 28, 2024

BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis

Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON,...

Find a provider near you or contact us today.

Find a Provider Contact Us